Stocktoria
Acumen Pharmaceuticals, Inc. ABOS
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-01
Acumen Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,158,661 | $5.2M | 3.56% |
| RENAISSANCE TECHNOLOGIES LLC | 675,025 | $1.8M | 1.11% |
| TWO SIGMA INVESTMENTS, LP | 622,882 | $1.7M | 1.03% |
| MILLENNIUM MANAGEMENT LLC | 60,598 | $161,797 | 0.1% |
| CITADEL ADVISORS LLC | 51,049 | $136,301 | 0.08% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.